Download Free Sample Report

A subcutaneous drug delivery device having a housing having an internal reservoir in communication with a drug delivery needle via a fluid path. An expandable chamber disposed adjacent to the reservoir forces drug from the reservoir to the needle when supplied with a gas.
This report contains market size and forecasts of Subcutaneous Drug Delivery Devices in global, including the following market information:

• Global Subcutaneous Drug Delivery Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Subcutaneous Drug Delivery Devices Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five Subcutaneous Drug Delivery Devices companies in 2021 (%)

The global Subcutaneous Drug Delivery Devices market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Prefilled Injectable Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Subcutaneous Drug Delivery Devices include BD, Insulet Corporation, Enable Injections, West Pharmaceutical Services, Inc, Ypsomed AG, Elcam Medical, Amgen and Wilhelm Haselmeier, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Subcutaneous Drug Delivery Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Subcutaneous Drug Delivery Devices Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Subcutaneous Drug Delivery Devices Market Segment Percentages, by Type, 2021 (%)

• Prefilled Injectable
• Filled Injectable

Global Subcutaneous Drug Delivery Devices Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Subcutaneous Drug Delivery Devices Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Others

Global Subcutaneous Drug Delivery Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Subcutaneous Drug Delivery Devices Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:

• Key companies Subcutaneous Drug Delivery Devices revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Subcutaneous Drug Delivery Devices revenues share in global market, 2021 (%)
• Key companies Subcutaneous Drug Delivery Devices sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Subcutaneous Drug Delivery Devices sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• BD
• Insulet Corporation
• Enable Injections
• West Pharmaceutical Services, Inc
• Ypsomed AG
• Elcam Medical
• Amgen
• Wilhelm Haselmeier